Side-by-side comparison of AI visibility scores, market position, and capabilities
McKinney TX direct-to-consumer life insurance (NYSE: GL) at $5.78B 2024 revenue (+6%); net income $1.07B (+10%), American Income Life union distribution, middle-income families competing with Aflac and Lincoln Benefit.
Globe Life Inc. is a McKinney, Texas-based life and supplemental health insurance holding company — publicly traded on the New York Stock Exchange (NYSE: GL) as an S&P 500 Financials component — distributing direct-to-consumer and agent-sold life insurance, supplemental health insurance, and accident coverage to middle-income American families across all 50 states through five operating divisions: American Income Life (labor union and affinity group market), Liberty National Life Division (home service and agency market), Globe Life Direct Response Division (direct mail and internet), Family Heritage Life (supplemental health), and United American Insurance (individual health), through approximately 8,000 employees and 10,000+ agents. In fiscal year 2024, Globe Life reported annual revenue of $5.78 billion (+6.07%), net income of $1.07 billion (+10%), and net income per diluted share of $11.94 (versus $10.07 in 2023), demonstrating consistent profitability improvement. The company (formerly known as Torchmark Corporation until its 2019 rebrand) has served financially underserved American families for over 70 years, offering face amounts from $5,000 to $100,000 in whole life and term life policies — a segment of the life insurance market where major carriers (MetLife, Prudential, New York Life) compete less aggressively because smaller face amounts generate lower individual premium revenue. CEO Matt Darden leads Globe Life's network of five distribution channels that reach different segments of the middle-income insurance market.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.